SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-154591
Filing Date
2016-11-03
Accepted
2016-11-03 16:34:41
Documents
43
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17205_110q.htm 10-Q 677985
2 EX-10.1 a16-17205_1ex10d1.htm EX-10.1 105893
3 EX-31.1 a16-17205_1ex31d1.htm EX-31.1 11121
4 EX-32.1 a16-17205_1ex32d1.htm EX-32.1 5432
  Complete submission text file 0001104659-16-154591.txt   3363818

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT espr-20160930.xml EX-101.INS 697515
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20160930.xsd EX-101.SCH 21966
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20160930_cal.xml EX-101.CAL 37236
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20160930_lab.xml EX-101.LAB 287558
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20160930_pre.xml EX-101.PRE 184039
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20160930_def.xml EX-101.DEF 94259
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 161972158
SIC: 2834 Pharmaceutical Preparations